Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 523 Leukemia, Myeloid, Acute 500 Neoplasms 382 Carcinoma, Non-Small-Cell Lung 381 Pancreatic Neoplasms 329 Precursor Cell Lymphoblastic Leukemia-Lymphoma 319 Multiple Myeloma 312 Glioblastoma 312 Melanoma 310 Prostatic Neoplasms 293 Leukemia 289 Neoplasm Metastasis 285 Brain Neoplasms 277 Lymphoma 271 Lung Neoplasms 270 Recurrence 267 Ovarian Neoplasms 247 Colorectal Neoplasms 246 Lymphoma, Non-Hodgkin 242 Leukemia, Lymphocytic, Chronic, B-Cell 231 Glioma 210 Myelodysplastic Syndromes 208 Lymphoma, Large B-Cell, Diffuse 187 Carcinoma, Hepatocellular 173 Lymphoma, Follicular 168 Head and Neck Neoplasms 162 Hodgkin Disease 160 Lymphoma, Mantle-Cell 155 Burkitt Lymphoma 154 Sarcoma 150

Interventions

pembrolizumab 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Non-small Cell Carcinoma × Clear all

NCT03991819 2025-12-05

BiniPembro

University Health Network, Toronto

Phase 1 Recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡